aluates Reports

$ 0.0

Automative

Global Intravitreal Injectable Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-39H8828

Global Intravitreal Injectable Market Outlook 2022

BUY CHAPTERS

Global Intravitreal Injectable Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-39H8828

Report

August 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Allergan plc

Eyepoint Pharmaceuticals

Genentech Inc

Kanghong Pharmaceutical

Regeneron Pharmaceuticals (Eylea)

Astellas Pharma

Clearside Biomedical

Bayer

Intravitreal Injectable Sales Market Size

The global Intravitreal Injectable market size was US$ 17970 million in 2024 and is forecast to a readjusted size of US$ 28700 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.

Intravitreal Injectable Sales Market

Intravitreal injectables are sterile pharmaceutical formulations administered directly into the vitreous humor of the eye using a fine needle. This route of administration allows for targeted delivery of medications—such as anti-VEGF agents, corticosteroids, or antibiotics—into the posterior segment of the eye, ensuring high local drug concentrations while minimizing systemic exposure. Intravitreal injections are commonly used to treat retinal diseases including age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and infectious endophthalmitis.

The global intravitreal injectable market has experienced steady growth in recent years, driven primarily by the rising prevalence of retinal disorders such as macular edema, age-related macular degeneration (AMD), and retinal vein occlusion (RVO). Leading pharmaceutical players in this space include Regeneron Pharmaceuticals (notably with Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, and Kanghong Pharmaceutical. These top five companies collectively account for over 70% of global market share, reflecting a relatively concentrated competitive landscape. North America currently dominates the global market, holding a share of more than 50%, followed by Europe and Asia-Pacific, each with shares exceeding 40%.

In terms of drug types, anti-VEGF (vascular endothelial growth factor) therapies represent the largest and most significant market segment, contributing to over 85% of total market revenue. These agents are highly effective in inhibiting abnormal blood vessel growth in the retina, making them the standard of care for diseases like AMD and diabetic macular edema (DME). Other therapeutic classes such as corticosteroids and antibiotics play smaller roles, typically in more specialized or adjunctive treatment scenarios.

The largest clinical application of intravitreal injectables is for macular edema, which continues to see a rise in incidence linked to diabetes and aging populations worldwide. Macular degeneration and RVO are also major contributors to demand, reinforcing the importance of targeted ophthalmic treatments. The increase in awareness, earlier diagnosis, and improved accessibility to eye care services are further driving market expansion across both developed and emerging regions.

Looking ahead, the market is expected to grow steadily due to increasing disease burden and product innovation. Notably, new players such as Astellas Pharma have begun entering the market, signaling a shift toward broader competition and possibly next-generation therapies with extended efficacy and dosing intervals. Advances in drug delivery systems, longer-acting formulations, and biosimilars are expected to further shape the landscape and offer new growth opportunities.

The global Intravitreal Injectable market is strategically segmented by company, region (country), by Drug, and by Disease. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Drug, and by Disease for 2020-2031.

Market Segmentation

Scope of Intravitreal Injectable Sales Market Report

Report Metric	Details
Report Name	Intravitreal Injectable Sales Market
Forecasted market size in 2031	US$ 28700 million
CAGR	7.1%
Forecasted years	2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)	Anti-VEGF Steroids Others
By Application: (Core Demand Driver vs Emerging Opportunity)	Macular Degeneration Macular Edema Uveitis Retinal Vein Occlusion Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company:	Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, Astellas Pharma, Clearside Biomedical, Bayer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Intravitreal Injectable market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Steroids in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Macular Edema in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Intravitreal Injectable value chain, addressing:

FAQ for this report

What is the Intravitreal Injectable Sales Market size in 2031?

Ans: The Intravitreal Injectable Sales Market size in 2031 will be US$ 28700 million.

What is the market share of major companies in Intravitreal Injectable Sales Market?

Ans: These top five companies collectively account for over 70% of global market share, reflecting a relatively concentrated competitive landscape.

What is the Intravitreal Injectable Sales Market share by type?

Ans: In terms of drug types, anti-VEGF (vascular endothelial growth factor) therapies represent the largest and most significant market segment, contributing to over 85% of total market revenue.

Who are the main players in the Intravitreal Injectable Sales Market report?

Ans: The main players in the Intravitreal Injectable Sales Market are Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, Astellas Pharma, Clearside Biomedical, Bayer

What are the Application segmentation covered in the Intravitreal Injectable Sales Market report?

Ans: The Applications covered in the Intravitreal Injectable Sales Market report are Macular Degeneration, Macular Edema, Uveitis, Retinal Vein Occlusion, Others

What are the Type segmentation covered in the Intravitreal Injectable Sales Market report?

Ans: The Types covered in the Intravitreal Injectable Sales Market report are Anti-VEGF, Steroids, Others

1 Report Overview

1.1 Study Scope

1.2 Market by Drug

1.2.1 Global Market Size Growth by Drug: 2020 VS 2024 VS 2031

1.2.2 Anti-VEGF

1.2.3 Steroids

1.2.4 Others

1.3 Market by Disease

1.3.1 Global Market Share by Disease: 2020 VS 2024 VS 2031

1.3.2 Macular Degeneration

1.3.3 Macular Edema

1.3.4 Uveitis

1.3.5 Retinal Vein Occlusion

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Intravitreal Injectable Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Intravitreal Injectable Revenue Market Share by Region (2020-2025)

2.4 Global Intravitreal Injectable Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Intravitreal Injectable Market Size and Prospective (2020-2031)

2.5.2 Europe Intravitreal Injectable Market Size and Prospective (2020-2031)

2.5.3 China Intravitreal Injectable Market Size and Prospective (2020-2031)

3 Breakdown Data by Drug

3.1 Global Intravitreal Injectable Historic Market Size by Drug (2020-2025)

3.2 Global Intravitreal Injectable Forecasted Market Size by Drug (2026-2031)

3.3 Different Types Intravitreal Injectable Representative Players

4 Breakdown Data by Disease

4.1 Global Intravitreal Injectable Historic Market Size by Disease (2020-2025)

4.2 Global Intravitreal Injectable Forecasted Market Size by Disease (2026-2031)

4.3 New Sources of Growth in Intravitreal Injectable Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Intravitreal Injectable Players by Revenue (2020-2025)

5.1.2 Global Intravitreal Injectable Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Intravitreal Injectable Revenue

5.4 Global Intravitreal Injectable Market Concentration Analysis

5.4.1 Global Intravitreal Injectable Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Intravitreal Injectable Revenue in 2024

5.5 Global Key Players of Intravitreal Injectable Head office and Area Served

5.6 Global Key Players of Intravitreal Injectable, Product and Application

5.7 Global Key Players of Intravitreal Injectable, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Intravitreal Injectable Revenue by Company (2020-2025)

6.1.2 North America Market Size by Drug

6.1.2.1 North America Intravitreal Injectable Market Size by Drug (2020-2025)

6.1.2.2 North America Intravitreal Injectable Market Share by Drug (2020-2025)

6.1.3 North America Market Size by Disease

6.1.3.1 North America Intravitreal Injectable Market Size by Disease (2020-2025)

6.1.3.2 North America Intravitreal Injectable Market Share by Disease (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Intravitreal Injectable Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Drug

6.2.2.1 Europe Intravitreal Injectable Market Size by Drug (2020-2025)

6.2.2.2 Europe Intravitreal Injectable Market Share by Drug (2020-2025)

6.2.3 Europe Market Size by Disease

6.2.3.1 Europe Intravitreal Injectable Market Size by Disease (2020-2025)

6.2.3.2 Europe Intravitreal Injectable Market Share by Disease (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Intravitreal Injectable Revenue by Company (2020-2025)

6.3.2 China Market Size by Drug

6.3.2.1 China Intravitreal Injectable Market Size by Drug (2020-2025)

6.3.2.2 China Intravitreal Injectable Market Share by Drug (2020-2025)

6.3.3 China Market Size by Disease

6.3.3.1 China Intravitreal Injectable Market Size by Disease (2020-2025)

6.3.3.2 China Intravitreal Injectable Market Share by Disease (2020-2025)

6.3.4 China Market Trend and Opportunities

7 Key Players Profiles

7.1 Regeneron Pharmaceuticals (Eylea)

7.1.1 Regeneron Pharmaceuticals (Eylea) Company Details

7.1.2 Regeneron Pharmaceuticals (Eylea) Business Overview

7.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Introduction

7.1.4 Regeneron Pharmaceuticals (Eylea) Revenue in Intravitreal Injectable Business (2020-2025)

7.1.5 Regeneron Pharmaceuticals (Eylea) Recent Development

7.2 Allergan

7.2.1 Allergan Company Details

7.2.2 Allergan Business Overview

7.2.3 Allergan Intravitreal Injectable Introduction

7.2.4 Allergan Revenue in Intravitreal Injectable Business (2020-2025)

7.2.5 Allergan Recent Development

7.3 EyePoint Pharmaceuticals

7.3.1 EyePoint Pharmaceuticals Company Details

7.3.2 EyePoint Pharmaceuticals Business Overview

7.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Introduction

7.3.4 EyePoint Pharmaceuticals Revenue in Intravitreal Injectable Business (2020-2025)

7.3.5 EyePoint Pharmaceuticals Recent Development

7.4 Genentech

7.4.1 Genentech Company Details

7.4.2 Genentech Business Overview

7.4.3 Genentech Intravitreal Injectable Introduction

7.4.4 Genentech Revenue in Intravitreal Injectable Business (2020-2025)

7.4.5 Genentech Recent Development

7.5 Kanghong Pharmaceutical

7.5.1 Kanghong Pharmaceutical Company Details

7.5.2 Kanghong Pharmaceutical Business Overview

7.5.3 Kanghong Pharmaceutical Intravitreal Injectable Introduction

7.5.4 Kanghong Pharmaceutical Revenue in Intravitreal Injectable Business (2020-2025)

7.5.5 Kanghong Pharmaceutical Recent Development

7.6 Astellas Pharma

7.6.1 Astellas Pharma Company Details

7.6.2 Astellas Pharma Business Overview

7.6.3 Astellas Pharma Intravitreal Injectable Introduction

7.6.4 Astellas Pharma Revenue in Intravitreal Injectable Business (2020-2025)

7.6.5 Astellas Pharma Recent Development

7.7 Clearside Biomedical

7.7.1 Clearside Biomedical Company Details

7.7.2 Clearside Biomedical Business Overview

7.7.3 Clearside Biomedical Intravitreal Injectable Introduction

7.7.4 Clearside Biomedical Revenue in Intravitreal Injectable Business (2020-2025)

7.7.5 Clearside Biomedical Recent Development

7.8 Bayer

7.8.1 Bayer Company Details

7.8.2 Bayer Business Overview

7.8.3 Bayer Intravitreal Injectable Introduction

7.8.4 Bayer Revenue in Intravitreal Injectable Business (2020-2025)

7.8.5 Bayer Recent Development

8 Intravitreal Injectable Market Dynamics

8.1 Intravitreal Injectable Industry Trends

8.2 Intravitreal Injectable Market Drivers

8.3 Intravitreal Injectable Market Challenges

8.4 Intravitreal Injectable Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Allergan plc

Eyepoint Pharmaceuticals

Genentech Inc

Kanghong Pharmaceutical

Regeneron Pharmaceuticals (Eylea)

Astellas Pharma

Clearside Biomedical

Bayer

List of Tables

Table 1. Global Intravitreal Injectable Market Size Growth Rate by Drug (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Intravitreal Injectable Market Size Growth by Disease (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Intravitreal Injectable Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Intravitreal Injectable Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Intravitreal Injectable Revenue Share by Region (2020-2025)

Table 6. Global Intravitreal Injectable Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Intravitreal Injectable Revenue Share Forecast by Region (2026-2031)

Table 8. Global Intravitreal Injectable Market Size by Drug (2020-2025) & (US$ Million)

Table 9. Global Intravitreal Injectable Revenue Market Share by Drug (2020-2025)

Table 10. Global Intravitreal Injectable Forecasted Market Size by Drug (2026-2031) & (US$ Million)

Table 11. Global Intravitreal Injectable Revenue Market Share by Drug (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Intravitreal Injectable Market Size by Disease (2020-2025) & (US$ Million)

Table 14. Global Intravitreal Injectable Revenue Market Share by Disease (2020-2025)

Table 15. Global Intravitreal Injectable Forecasted Market Size by Disease (2026-2031) & (US$ Million)

Table 16. Global Intravitreal Injectable Revenue Market Share by Disease (2026-2031)

Table 17. New Sources of Growth in Intravitreal Injectable Application

Table 18. Global Intravitreal Injectable Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Intravitreal Injectable Market Share by Players (2020-2025)

Table 20. Global Top Intravitreal Injectable Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravitreal Injectable as of 2024)

Table 21. Ranking of Global Top Intravitreal Injectable Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Intravitreal Injectable Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Intravitreal Injectable, Headquarters and Area Served

Table 24. Global Key Players of Intravitreal Injectable, Product and Application

Table 25. Global Key Players of Intravitreal Injectable, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Intravitreal Injectable Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Intravitreal Injectable Revenue Market Share by Company (2020-2025)

Table 29. North America Intravitreal Injectable Market Size by Drug (2020-2025) & (US$ Million)

Table 30. North America Intravitreal Injectable Market Size by Disease (2020-2025) & (US$ Million)

Table 31. Europe Intravitreal Injectable Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Intravitreal Injectable Revenue Market Share by Company (2020-2025)

Table 33. Europe Intravitreal Injectable Market Size by Drug (2020-2025) & (US$ Million)

Table 34. Europe Intravitreal Injectable Market Size by Disease (2020-2025) & (US$ Million)

Table 35. China Intravitreal Injectable Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Intravitreal Injectable Revenue Market Share by Company (2020-2025)

Table 37. China Intravitreal Injectable Market Size by Drug (2020-2025) & (US$ Million)

Table 38. China Intravitreal Injectable Market Size by Disease (2020-2025) & (US$ Million)

Table 39. Regeneron Pharmaceuticals (Eylea) Company Details

Table 40. Regeneron Pharmaceuticals (Eylea) Business Overview

Table 41. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product

Table 42. Regeneron Pharmaceuticals (Eylea) Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 43. Regeneron Pharmaceuticals (Eylea) Recent Development

Table 44. Allergan Company Details

Table 45. Allergan Business Overview

Table 46. Allergan Intravitreal Injectable Product

Table 47. Allergan Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 48. Allergan Recent Development

Table 49. EyePoint Pharmaceuticals Company Details

Table 50. EyePoint Pharmaceuticals Business Overview

Table 51. EyePoint Pharmaceuticals Intravitreal Injectable Product

Table 52. EyePoint Pharmaceuticals Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 53. EyePoint Pharmaceuticals Recent Development

Table 54. Genentech Company Details

Table 55. Genentech Business Overview

Table 56. Genentech Intravitreal Injectable Product

Table 57. Genentech Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 58. Genentech Recent Development

Table 59. Kanghong Pharmaceutical Company Details

Table 60. Kanghong Pharmaceutical Business Overview

Table 61. Kanghong Pharmaceutical Intravitreal Injectable Product

Table 62. Kanghong Pharmaceutical Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 63. Kanghong Pharmaceutical Recent Development

Table 64. Astellas Pharma Company Details

Table 65. Astellas Pharma Business Overview

Table 66. Astellas Pharma Intravitreal Injectable Product

Table 67. Astellas Pharma Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 68. Astellas Pharma Recent Development

Table 69. Clearside Biomedical Company Details

Table 70. Clearside Biomedical Business Overview

Table 71. Clearside Biomedical Intravitreal Injectable Product

Table 72. Clearside Biomedical Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 73. Clearside Biomedical Recent Development

Table 74. Bayer Company Details

Table 75. Bayer Business Overview

Table 76. Bayer Intravitreal Injectable Product

Table 77. Bayer Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 78. Bayer Recent Development

Table 79. Intravitreal Injectable Market Trends

Table 80. Intravitreal Injectable Market Drivers

Table 81. Intravitreal Injectable Market Challenges

Table 82. Intravitreal Injectable Market Restraints

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

List of Figures

Figure 1. Intravitreal Injectable Product Picture

Figure 2. Global Intravitreal Injectable Market Share by Drug: 2024 VS 2031

Figure 3. Anti-VEGF Features

Figure 4. Steroids Features

Figure 5. Others Features

Figure 6. Global Intravitreal Injectable Market Share by Disease: 2024 VS 2031

Figure 7. Macular Degeneration

Figure 8. Macular Edema

Figure 9. Uveitis

Figure 10. Retinal Vein Occlusion

Figure 11. Others

Figure 12. Intravitreal Injectable Report Years Considered

Figure 13. Global Intravitreal Injectable Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Intravitreal Injectable Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Intravitreal Injectable Revenue Market Share by Region: 2020 VS 2024

Figure 16. North America Intravitreal Injectable Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Europe Intravitreal Injectable Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. China Intravitreal Injectable Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. Global Intravitreal Injectable Market Share by Players in 2024

Figure 20. Global Top Intravitreal Injectable Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravitreal Injectable as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Intravitreal Injectable Revenue in 2024

Figure 22. North America Intravitreal Injectable Market Share by Drug (2020-2025)

Figure 23. North America Intravitreal Injectable Market Share by Disease (2020-2025)

Figure 24. Europe Intravitreal Injectable Market Share by Drug (2020-2025)

Figure 25. Europe Intravitreal Injectable Market Share by Disease (2020-2025)

Figure 26. China Intravitreal Injectable Market Share by Drug (2020-2025)

Figure 27. China Intravitreal Injectable Market Share by Disease (2020-2025)

Figure 28. Regeneron Pharmaceuticals (Eylea) Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 29. Allergan Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 30. EyePoint Pharmaceuticals Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 31. Genentech Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 32. Kanghong Pharmaceutical Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 33. Astellas Pharma Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 34. Clearside Biomedical Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 35. Bayer Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 36. Bottom-up and Top-down Approaches for This Report

Figure 37. Data Triangulation

Figure 38. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4250

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6375

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Intravitreal Injection Market Research Report 2024

Global Robotic Intravitreal Injection System Market Research Report 2024

Global Intravitreal Injection of Anti VEGF Drugs Market Research Report 2024

Global Intraocular Injections Market Research Report 2024

Global Anti VEGF Intravitreal Drugs Market Research Report 2024

Global Implantable Ophthalmic Drugs Market Research Report 2025

Global Ranibizumab Injection Market Research Report 2024

Global Injectable Regenerative Graft Market Research Report 2024

Retinal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intravitreal Implant Market Research Report 2024

Global Retinal Vasculitis Treatment Market Research Report 2025

Global Cytomegalovirus Retinitis Treatment Market Research Report 2024

Global Vitreo Retinal Prefilled Silicone Oil Syringe Market Insights Forecast to 2030

Vitreo Retinal Surgery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Retinal Dystrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Disposable Intraocular Lens Injector Market Research Report 2024

Ophthalmic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global High Acuity Care Service Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5D18285

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global mHealth (Mobile Health) Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18B6151

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Resin Lenses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-21S7871

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mobile Medical Imaging Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16Q6154

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions